OrbiMed
OrbiMed is a global investment firm specializing in the healthcare sector. With over 25 years of experience, OrbiMed invests in companies across the healthcare industry, including biopharmaceuticals, medical devices, diagnostics, and healthcare services. The firm manages approximately $18 billion in assets and operates from multiple global locations, aiming to drive innovation and improve patient outcomes through strategic investments.
Industries
N/A
Nr. of Employees
small (1-50)
Portfolio
Developing a proprietary RNA targeting platform for life-saving therapeutics.
#Biopharmaceuticals
Applies precision medicine to develop life-changing medicines for rare diseases and cancer.
#Biopharmaceuticals
Focuses on targeted oncology drug discovery using mechanistic biology and medicinal chemistry.
#Biopharmaceuticals
Developing a proprietary RNA targeting platform for life-saving therapeutics.
#Biopharmaceuticals
Applies precision medicine to develop life-changing medicines for rare diseases and cancer.
#Biopharmaceuticals
Focuses on targeted oncology drug discovery using mechanistic biology and medicinal chemistry.
#Biopharmaceuticals